GLP Watchdog

LevelsRx vs Mochi Health

Neither LevelsRx nor Mochi Health has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

LevelsRx / Mochi Health

LevelsRx logo

LevelsRx

6.9/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$110/moFoundayo (orforglipron) pill
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit LevelsRx
Visit Mochi Health

Neither LevelsRx nor Mochi Health pays us. Links to them earn nothing. Scores: LevelsRx 6.9, Mochi Health 7.1. How we are paid

What the record shows

  1. 01

    Neither LevelsRx nor Mochi Health has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear.

  4. 04

    Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

  5. 05

    Mochi Health lists all 50 states. LevelsRx publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

LevelsRx

Mochi Health

Compounded semaglutide injection

$249/mo

$2,988 a year

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection

$299/mo

$3,588 a year

$169/mo

plan terms unclear; not compared

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral semaglutide
Not sold or not priced

$141/mo

$1,692 a year

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$110/mo

$1,320 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
Only for medical disqualification before services begin, billing errors, or the weight-loss guarantee
No refunds for partly used periods; medication is not refundable once sent to the pharmacy
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. LevelsRx: October 17, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for LevelsRx

6.9/10

The record gives LevelsRx no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
Visit LevelsRx

The case for Mochi Health

7.1/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which LevelsRx does not price
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

Scores

LevelsRx 6.9 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

4.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

6.5A
vs
B
8.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

LevelsRx vs Mochi Health: questions

Neither LevelsRx nor Mochi Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like. They share compounded semaglutide injection, but Mochi Health's $139 comes with plan terms the seller's page leaves unclear. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
LevelsRx states you can cancel at any time; refunds: only for medical disqualification before services begin, billing errors, or the weight-loss guarantee. Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Neither LevelsRx nor Mochi Health pays us. Links to them earn nothing. Scores: LevelsRx 6.9, Mochi Health 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks